+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Industry Trends Analysis Report by Type, Regional Outlook and Forecast, 2022-2028 - Product Thumbnail Image

Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Industry Trends Analysis Report by Type, Regional Outlook and Forecast, 2022-2028

  • Report
  • March 2023
  • 130 Pages
  • Global
From
Hydrocortisone-17-butyrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Hydrocortisone-17-butyrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 94 Pages
  • Global
From
Magaldrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Magaldrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 92 Pages
  • Global
From
Potassium Phosphate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Potassium Phosphate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 101 Pages
  • Global
From
Magnesium Citrate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Magnesium Citrate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 109 Pages
  • Global
From
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 38 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Gastritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 93 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Eosinophilic Esophagitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 151 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
US Ulcerative Colitis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Ulcerative Colitis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Clostridium Difficile-Associated Diarrhea Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Clostridium Difficile-Associated Diarrhea Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Gastro-Esophageal Reflux Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Gastro-Esophageal Reflux Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Irritable Bowel Syndrome Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Irritable Bowel Syndrome Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Celiac Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Celiac Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Pancreatitis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Pancreatitis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Constipation-Predominant Irritable Bowel Syndrome Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Constipation-Predominant Irritable Bowel Syndrome Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Gastroparesis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Gastroparesis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Celiac Disease Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Celiac Disease Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more